Evidence map›Paper›PMID 37633871›Full record

ArticleAMB Express2023

Construction of a bacteriophage-derived recombinase system in Bacillus licheniformis for gene deletion.

Fang Xue, Xufan Ma, Cheng Luo, Dongliang Li, Guiyang Shi, Youran Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AMB Express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Establishment of the CRISPR-Cpf1 gene editing system inSynthetic and systems biotechnology · 2025
    Article
  3. AdvancingMicroorganisms · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fang XueKey Laboratory of Chinese Cigar Fermentation, Cigar Technology Innovation Center of China Tobacco, Tobacco Sichuan Industrial Co., Ltd, Chengdu, 610000, P. R. China.
Xufan MaNational Engineering Research Center for Cereal Fermentation and Food Biomanufacturing, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, P. R. China.
Cheng LuoKey Laboratory of Chinese Cigar Fermentation, Cigar Technology Innovation Center of China Tobacco, Tobacco Sichuan Industrial Co., Ltd, Chengdu, 610000, P. R. China.
Dongliang LiKey Laboratory of Chinese Cigar Fermentation, Cigar Technology Innovation Center of China Tobacco, Tobacco Sichuan Industrial Co., Ltd, Chengdu, 610000, P. R. China.
Guiyang ShiNational Engineering Research Center for Cereal Fermentation and Food Biomanufacturing, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, P. R. China.
Youran LiNational Engineering Research Center for Cereal Fermentation and Food Biomanufacturing, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, P. R. China. liyouran@jiangnan.edu.cn.
China Tobacco · CNJiangnan University · CN

Funding

Key Technologies Research and Development Program 2020YFA0907700Major Science and Technology Program of China National Tobacco Corporation 110202101066(XJ-15) and (110202101014(XJ-06)National Natural Science Foundation of China 32172174
6 · The paper itself

Abstract

Bacillus licheniformis and its related strains have found extensive applications in diverse industries, agriculture, and medicine. However, the current breeding methods for this strain primarily rely on natural screening and traditional mutagenesis. The limited availability of efficient genetic engineering tools, particularly recombination techniques, has hindered further advancements in its applications. In this study, we conducted a comprehensive investigation to identify and characterize a recombinase, RecT, derived from a Bacillus phage. Remarkably, the recombinase exhibited a 10

Indexed as

Bacillus licheniformisHomologous recombinationRecombinase RecT

Identifiers

PMID37633871
PMCPMC10460339
OpenAlexW4386189573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.